Psychostimulant addiction treatment

Al Suwaidi, 2013, Cardiovascular complications of Khat, Clin. Chim. Acta, 419, 11, 10.1016/j.cca.2013.01.007 Al'Absi, 2012, Concurrent use of tobacco and Khat: added burden on chronic disease epidemic, Addiction, 107, 451, 10.1111/j.1360-0443.2011.03684.x American Psychiatric Association, 2013 Anderson, 2012, Modafinil for the treatment of methamphetamine dependence, Drug Alcohol Depend., 120, 135, 10.1016/j.drugalcdep.2011.07.007 Andrade, 2012, The impact of contingency management on quality of life among cocaine abusers with and without alcohol dependence, Am. J. Addict., 21, 47, 10.1111/j.1521-0391.2011.00185.x Arria, 2010, Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do, J. Addict. Dis., 29, 417, 10.1080/10550887.2010.509273 Barnett, 1981, Cocaine pharmacokinetics in humans, J. Ethnopharmacol., 3, 353, 10.1016/0378-8741(81)90063-5 Bradley, 1937, The behavior of children receiving benzedrine, Am. J. Psychiatry, 94, 577, 10.1176/ajp.94.3.577 Carroll, 1996, Relapse prevention as a psychosocial treatment: a review of controlled clinical trials, Exp. Clin. Psychopharmacol., 4, 46, 10.1037/1064-1297.4.1.46 Carroll, 1997, Manual-guided psychosocial treatment – a new virtual requirement for pharmacotherapy trials?, Arch. Gen. Psychiatry, 54, 923, 10.1001/archpsyc.1997.01830220041007 Carroll, 1998, A Cognitive-Behavioral Approach: Treating Cocaine Addiction, 10.1037/e722512007-001 Carroll, 2000 Carroll, 2004, Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients – a randomized placebo-controlled trial, Arch. Gen. Psychiatry, 61, 264, 10.1001/archpsyc.61.3.264 Carroll, 2012, Efficacy of disulfiram and twelve step facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial, Drug Alcohol Depend., 126, 224, 10.1016/j.drugalcdep.2012.05.019 Carvalho, 2012, Toxicity of amphetamines: an update, Arch. Toxicol., 86, 1167, 10.1007/s00204-012-0815-5 Childress, 2013, The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD, Expert Rev. Neurother, 13, 979, 10.1586/14737175.2013.833002 Chiu, 2005, Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone, Brain Res. Bull., 67, 100, 10.1016/j.brainresbull.2005.05.028 Ciccarone, 2011, Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy, Prim. Care, 38, 41, 10.1016/j.pop.2010.11.004 Clinical Textbook of Addictive Disorders. 2005. Frances, R.J., Miller, S.I., Mack, A.H.(Eds.), third ed. The Guilford Press, New York. Coffey, 2000, Acute and protracted cocaine abstinence in an outpatient population: a prospective study of mood, sleep and withdrawal symptoms, Drug Alcohol Depend., 59, 277, 10.1016/S0376-8716(99)00126-X Coffin, 2013, Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial, Addiction, 108, 751, 10.1111/add.12073 Cruickshank, 2009, A review of the clinical pharmacology of methamphetamine, Addiction, 104, 1085, 10.1111/j.1360-0443.2009.02564.x Cruickshank, 2008, A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal, Drug Alcohol Rev., 27, 326, 10.1080/09595230801935672 Dackis, 2012, A double-blind, placebo-controlled trial of modafinil for cocaine dependence, J. Subst. Abuse Treat., 43, 303, 10.1016/j.jsat.2011.12.014 Dackis, 2003, Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study, Drug Alcohol Depend., 70, 29, 10.1016/S0376-8716(02)00335-6 Darker, 2012, Cognitive behavioural coping skills therapy in cocaine using methadone maintained patients: a pilot randomised controlled trial, Heroin Addict. Relat. Clin. Probl., 14, 101 De Sousa, 2008, An open randomized trial comparing disulfiram and naltrexone in adolescents with alcohol dependence, J. Subst. Use, 13, 382, 10.1080/14659890802305861 Deas, 2005, Naltrexone treatment of adolescent alcoholics: an open-label pilot study, J. Child. Adolesc. Psychopharmacol., 15, 723, 10.1089/cap.2005.15.723 Devoto, 2012, Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex, Psychopharmacology, 219, 1153, 10.1007/s00213-011-2447-5 Dopheide, 2009, Attention-deficit-hyperactivity disorder: an update, Pharmacotherapy, 29, 656, 10.1592/phco.29.6.656 Dutra, 2008, A meta-analytic review of psychosocial interventions for substance use disorders, Am. J. Psychiatry, 165, 179, 10.1176/appi.ajp.2007.06111851 Eiler, 1995, Double-blind comparison of bromocriptine and placebo in cocaine withdrawal, Am. J. Drug Alcohol Abuse, 21, 65, 10.3109/00952999509095230 Elkashef, 2008, Bupropion for the treatment of methamphetamine dependence, Neuropsychopharmacology, 33, 1162, 10.1038/sj.npp.1301481 Ellinwood, 1989, Dose- and time-dependent effects of stimulants, NIDA Res. Monogr., 94, 323 Epstein, 2003, Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up, Psychol. Addict. Behav., 17, 73, 10.1037/0893-164X.17.1.73 Fasano, 2008, Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding, Drug Alcohol Depend., 96, 178, 10.1016/j.drugalcdep.2008.02.005 Foltin, 1997, A laboratory model of cocaine withdrawal in humans: intravenous cocaine, Exp. Clin. Psychopharmacol., 5, 404, 10.1037/1064-1297.5.4.404 Galloway, 2011, A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction, Clin. Pharmacol. Ther., 89, 276, 10.1038/clpt.2010.307 Garbutt, 2010, Efficacy and tolerability of naltrexone in the management of alcohol dependence, Curr. Pharm. Des., 16, 2091, 10.2174/138161210791516459 Gardner, 2007, Therapeutic options and challenges for substances of abuse, Dialogues Clin. Neurosci., 9, 431, 10.31887/DCNS.2007.9.4/tgardner Gawin, 1986, Abstinence symptomatology and psychiatric-diagnosis in cocaine abusers - clinical observations, Arch. Gen. Psychiatry, 43, 107, 10.1001/archpsyc.1986.01800020013003 Gay, 1982, Clinical management of acute and chronic cocaine poisoning, Ann. Emerg. Med., 11, 562, 10.1016/S0196-0644(82)80434-4 George, 2000, Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial, Biol. Psychiatry, 47, 1080, 10.1016/S0006-3223(99)00310-8 Giannini, 1986, Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine, J. Clin. Pharmacol., 26, 211, 10.1002/j.1552-4604.1986.tb02936.x Goodwin, 2009, Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo, J. Biol. Chem., 284, 2978, 10.1074/jbc.M805298200 Gorelick, 2005, Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving, Biol. Psychiatry, 57, 1573, 10.1016/j.biopsych.2005.02.026 Grabowski, 2001, Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial, J. Clin. Psychopharmacol., 21, 522, 10.1097/00004714-200110000-00010 Grabowski, 1997, Replacement medication for cocaine dependence: methylphenidate, J. Clin. Psychopharmacol., 17, 485, 10.1097/00004714-199712000-00008 Greenway, 2005, Safety of obesity drugs, Expert Opin. Drug Saf., 4, 1083, 10.1517/14740338.4.6.1083 Gross, 1995, Origin of stimulant use for treatment of attention-deficit disorder, Am. J. Psychiatry, 152, 298, 10.1176/ajp.152.2.298b Haggkvist, 2011, Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat, Addict. Biol., 16, 20, 10.1111/j.1369-1600.2009.00199.x Haney, 2010, Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans, Biol. Psychiatry, 67, 59, 10.1016/j.biopsych.2009.08.031 Hatsukami, 1996, Crack cocaine and cocaine hydrochloride - are the differences myth or reality?, Jama-J. Am. Med. Assoc., 276, 1580, 10.1001/jama.1996.03540190052029 Herin, 2010, Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies, vol. 1187, 76 Ishizaka, 2007, E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant, Expert Rev. Vaccines, 6, 773, 10.1586/14760584.6.5.773 Jayaram-Lindstrom, 2008, Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence, Neuropsychopharmacology, 33, 1856, 10.1038/sj.npp.1301572 Jenkins, 2002, Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration, J. Anal. Toxicol., 26, 382, 10.1093/jat/26.7.382 Kalix, 1991, Khat, a plant drug with amphetamine properties, Schweiz. Med. Wochenschr., 121, 1561 Karch, 2005, Cocaine cardiovascular toxicity, South. Med. J., 98, 794, 10.1097/01.smj.0000168701.08879.3f Koob, 1988, Cellular and molecular mechanisms of drug-dependence, Science, 242, 715, 10.1126/science.2903550 Kosten, 2013, Can you vaccinate against substance abuse?, Expert Opin. Biol. Ther., 13, 1093, 10.1517/14712598.2013.791278 Kosten, 2002, Human therapeutic cocaine vaccine: safety and immunogenicity, Vaccine, 20, 1196, 10.1016/S0264-410X(01)00425-X Kosten, 2013, Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine beta-hydroxylase, Biol. Psychiatry, 73, 219, 10.1016/j.biopsych.2012.07.011 Lee, 2008, A systematic review of cognitive and behavioural therapies for methamphetamine dependence, Drug Alcohol Rev., 27, 309, 10.1080/09595230801919494 Lima, 2002, Carbamazepine for cocaine dependence, Cochrane Database Syst. Rev., CD002023 Lima, 2003, Antidepressants for cocaine dependence, Cochrane Database Syst. Rev., CD002950 Llosa, 2005 Lott, 2006, Serotonin transporter genotype and acute subjective response to amphetamine, Am. J. Addict., 15, 327, 10.1080/10550490600859868 Martell, 2005, Vaccine pharmacotherapy for the treatment of cocaine dependence, Biol. Psychiatry, 58, 158, 10.1016/j.biopsych.2005.04.032 Martell, 2009, Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients a randomized, double-blind, placebo-controlled efficacy trial, Arch. General Psychiatry, 66, 1116, 10.1001/archgenpsychiatry.2009.128 Maude-Griffin, 1998, Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects, J. Consult. Clin. Psychol., 66, 832, 10.1037/0022-006X.66.5.832 McDonell, 2013, Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness, Am. J. Psychiatry, 170, 94, 10.1176/appi.ajp.2012.11121831 Mello, 2007, Effects of d-amphetamine and buprenorphine combinations on speedball (cocaine plus heroin) self-administration by rhesus monkeys, Neuropsychopharmacology, 32, 1985, 10.1038/sj.npp.1301319 Mereu, 2013, The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders, Psychopharmacology, 229, 415, 10.1007/s00213-013-3232-4 Miles, 2013, Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial, Addiction, 108, 1279, 10.1111/add.12109 Minozzi, 2008, Anticonvulsants for cocaine dependence, Cochrane Database Syst. Rev., 16, 10.1002/14651858.CD006754.pub2 Mooney, 2009, Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial, Drug Alcohol Depend., 101, 34, 10.1016/j.drugalcdep.2008.10.016 Morgan, 1988, A pilot trial of amantadine for ambulatory withdrawal for cocaine dependence, NIDA Res. Monogr., 81, 81 Morgenthaler, 2007, Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin, Sleep, 30, 1705, 10.1093/sleep/30.12.1705 Negus, 2003, Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys, Psychopharmacology, 167, 324, 10.1007/s00213-003-1409-y Newton, 2012, Noradrenergic alpha(1) receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial, Plos One, 7, 10.1371/journal.pone.0030854 Nich, 2004, Sex differences in cocaine-dependent individuals' response to disulfiram treatment, Addict. Behav., 29, 1123, 10.1016/j.addbeh.2004.03.004 Oliveto, 2001, Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers, Drug Alcohol Depend., 63, 155, 10.1016/S0376-8716(00)00198-8 Oliveto, 2011, Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients, Drug Alcohol Depend., 113, 184, 10.1016/j.drugalcdep.2010.07.022 Pani, 2011, Antidepressants for cocaine dependence and problematic cocaine use, Cochrane Database Syst. Rev. Petry, 2013, A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders, Drug Alcohol Depend., 130, 234, 10.1016/j.drugalcdep.2012.10.017 Rasmussen, 2006, Making the first anti-depressant: amphetamine in American medicine, 1929-1950, J. Hist. Med. Allied Sci., 61, 288, 10.1093/jhmas/jrj039 Robinson, 2008, The incentive sensitization theory of addiction: some current issues, Philos. Trans. R. Soc. B-Biol. Sci., 363, 3137, 10.1098/rstb.2008.0093 Rohsenow, 2000, Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes, J. Consult. Clin. Psychol., 68, 515, 10.1037/0022-006X.68.3.515 Roll, 2013, Duration effects in contingency management treatment of methamphetamine disorders, Addict. Behav., 38, 2455, 10.1016/j.addbeh.2013.03.018 Roll, 2006, Contingency management for the treatment of methamphetamine use disorders, Am. J. Psychiatry, 163, 1993, 10.1176/ajp.2006.163.11.1993 Romanelli, 2006, Clinical effects and management of methamphetamine abuse, Pharmacotherapy, 26, 1148, 10.1592/phco.26.8.1148 Roth, 1988, Acute rhabdomyolysis associated with cocaine intoxication, N. Engl. J. Med., 319, 673, 10.1056/NEJM198809153191103 Rothman, 2000, Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction, Neurobiol. Mech. Drugs Abuse: Cocaine, Ibogaine, Substit. Amphetamines, 914, 71 Sabioni, 2013, The effectiveness of treatments for cocaine dependence in Schizophrenic patients: a systematic review, Curr. Neuropharmacol., 11, 484, 10.2174/1570159X11311050003 Schep, 2010, The clinical toxicology of metamfetamine, Clin. Toxicol., 48, 675, 10.3109/15563650.2010.516752 Schmitz, 2012, Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation, Front. Psychiatry, 3, 77, 10.3389/fpsyt.2012.00077 Secades-Villa, 2013, Contingency management is effective across cocaine-dependent outpatients with different socioeconomic status, J. Subst. Abuse Treat., 44, 349, 10.1016/j.jsat.2012.08.018 Secades-Villa, 2011, Community reinforcement approach plus vouchers among cocaine-dependent outpatients: twelve-month outcomes, Psychol. Addict. Behav., 25, 174, 10.1037/a0021451 Sembower, 2013, Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States, J. Addict. Dis., 32, 26, 10.1080/10550887.2012.759880 Setiawan, 2011, The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype, Alcohol-Clin. Exp. Res., 35, 1134, 10.1111/j.1530-0277.2011.01446.x Shearer, 2009, A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence, Addiction, 104, 224, 10.1111/j.1360-0443.2008.02437.x Shen, 2013, A vaccine against methamphetamine attenuates its behavioral effects in mice, Drug Alcohol Depend., 129, 41, 10.1016/j.drugalcdep.2012.09.007 Shesser, 1991, The contribution of impurities to the acute morbidity of illegal drug-use, Am. J. Emerg. Med., 9, 336, 10.1016/0735-6757(91)90053-M Shorter, 2013, The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: a pilot study, Drug Alcohol Depend., 131, 66 Soares, 2003, Dopamine agonists for cocaine dependence, Cochrane Database Syst. Rev., 10.1002/14651858.CD003352 Sofuoglu, 2013, Cognitive enhancement as a treatment for drug addictions, Neuropharmacology, 64, 452, 10.1016/j.neuropharm.2012.06.021 Spellicy, 2013, ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse, Pharmacogenetics Genomics, 23, 333, 10.1097/FPC.0b013e328361c39d Stoops, 2012, Influence of acute bupropion pre-treatment on the effects of intranasal cocaine, Addiction, 107, 1140, 10.1111/j.1360-0443.2011.03766.x Substance Abuse and Mental Health Services Administration, 2011 Sulaiman, 2013, A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis, Int. J. Psychiatry Clin. Pract., 17, 131, 10.3109/13651501.2012.667116 Sweeney, 2013, Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse, J. Addict. Dis., 32, 1, 10.1080/10550887.2012.759858 Tennant, 1984, Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence, NIDA Res. Monogr., 55, 159 Tennant, 1987, Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence, Arch. Intern. Med., 147, 109, 10.1001/archinte.1987.00370010109025 United Nations Office on Drugs and Crime, 2012 Vocci, 2009, Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence, Curr. Opin. Psychiatry, 22, 263, 10.1097/YCO.0b013e32832a3b44 Volkow, 2001, Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers, Am. J. Psychiatry, 158, 377, 10.1176/appi.ajp.158.3.377 Weddington, 1990, Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts - a controlled, residential study, Arch. General Psychiatry, 47, 861, 10.1001/archpsyc.1990.01810210069010 White, 1998, Neuroadaptations involved in amphetamine and cocaine addiction, Drug Alcohol Depend., 51, 141, 10.1016/S0376-8716(98)00072-6 Winger, 2004 Yamamoto, 2010, Amphetamine toxicities classical and emerging mechanisms, Addict. Rev., 2, 101 Zhu, 2011, Methylphenidate and mu opioid receptor interactions: a pharmacological target for prevention of stimulant abuse, Neuropharmacology, 61, 283, 10.1016/j.neuropharm.2011.04.015